Published in Int J Cancer on February 01, 2011
Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases. World J Surg Oncol (2013) 1.06
Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report. Oncol Lett (2015) 0.81
EGFR and KRAS mutations in pulmonary pleomorphic carcinoma and their correlation with clinicopathologic features. Contemp Oncol (Pozn) (2015) 0.78
Clinical Significance and Next-Generation Sequencing of Chinese Pulmonary Sarcomatoid Carcinoma. Sci Rep (2017) 0.75
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol (2012) 22.04
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy. J Clin Oncol (2004) 12.89
Second-line treatment of advanced non-small cell lung cancer. J Thorac Oncol (2008) 3.95
Phase III study of carboplatin and paclitaxel alone or with sorafenib in advanced non-small-cell lung cancer. J Clin Oncol (2010) 3.13
Solitary fibrous tumors of the pleura: an analysis of 110 patients treated in a single institution. Ann Thorac Surg (2009) 1.96
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer. Oncogene (2003) 1.88
Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol (2009) 1.68
Interventional endoscopy in the management of benign tracheal stenoses: definitive treatment at long-term follow-up. Eur J Cardiothorac Surg (2008) 1.53
Mechanical ventilation in patients with end-stage idiopathic pulmonary fibrosis. Respiration (2009) 1.43
Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment? Am J Gastroenterol (2002) 1.39
Neurotrophin and neurotrophin receptor protein expression in the human lung. Am J Respir Cell Mol Biol (2003) 1.38
Bronchial carcinoid tumors: nodal status and long-term survival after resection. Ann Thorac Surg (2004) 1.33
Short hydration regimen and nephrotoxicity of intermediate to high-dose cisplatin-based chemotherapy for outpatient treatment in lung cancer and mesothelioma. Tumori (2007) 1.27
Chickenpox in unexplained pulmonary necrotizing granulomas. Chest (2014) 1.27
Surgical repair of post-traumatic lung hernia using a video-assisted open technique. Interact Cardiovasc Thorac Surg (2008) 1.25
The role of bevacizumab in the treatment of non-small cell lung cancer: current indications and future developments. Oncologist (2007) 1.20
Congenital diarrheal disorders: improved understanding of gene defects is leading to advances in intestinal physiology and clinical management. J Pediatr Gastroenterol Nutr (2010) 1.16
Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel. J Clin Oncol (2005) 1.16
Intracranial pressure in unresponsive chronic migraine. J Neurol (2014) 1.14
The role of histology with common first-line regimens for advanced non-small cell lung cancer: a brief report of the retrospective analysis of a three-arm randomized trial. J Thorac Oncol (2009) 1.13
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer. Lung Cancer (2009) 1.11
Early stage non-small-cell lung cancer: surgical implications of the new adenocarcinoma classification. J Thorac Oncol (2013) 1.10
Artifacts, Noise and Interference: Much Ado about Ultrasound. Respiration (2015) 1.10
Pemetrexed in the treatment of advanced non-squamous lung cancer. Lung Cancer (2009) 1.07
Role of human neutrophil peptides in lung inflammation associated with alpha1-antitrypsin deficiency. Am J Physiol Lung Cell Mol Physiol (2003) 1.07
Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series. J Thorac Oncol (2012) 1.07
ΔNp63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach. J Thorac Oncol (2012) 1.04
Supportive care in patients with advanced non-small-cell lung cancer. Br J Cancer (2003) 1.04
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis. Lung Cancer (2010) 1.03
A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments. Int J Surg Pathol (2009) 1.02
Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets. Arch Pathol Lab Med (2012) 1.02
Primary neuroendocrine tumours of the thymus: a clinicopathologic and prognostic study in 19 patients. Eur J Cardiothorac Surg (2009) 1.02
Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene. Lung Cancer (2012) 1.02
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. Ann Thorac Surg (2012) 1.01
A polymer-based functional pattern on one-dimensional photonic crystals for photon sorting of fluorescence radiation. Opt Express (2012) 1.00
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases. Sci Rep (2015) 0.99
Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology (2004) 0.98
miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas. Am J Surg Pathol (2011) 0.97
Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Lung Cancer (2006) 0.96
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications. PLoS One (2012) 0.96
HRCT and histopathological evaluation of fibrosis and tissue destruction in IPF associated with pulmonary emphysema. Respir Med (2008) 0.95
A rare case of primary pulmonary epithelioid angiosarcoma detected by (18)F-FDG PET/CT. Clin Nucl Med (2014) 0.95
Music for colonoscopy: A single-blind randomized controlled trial. Dig Liver Dis (2010) 0.94
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid. Clin Nucl Med (2015) 0.94
Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer. J Clin Oncol (2009) 0.93
A fluorescent one-dimensional photonic crystal for label-free biosensing based on BLOCH surface waves. Sensors (Basel) (2013) 0.93
Early and late outcome after surgical treatment of acquired non-malignant tracheo-oesophageal fistulae. Eur J Cardiothorac Surg (2013) 0.93
Role of colony stimulating factors (CSFs) in solid tumours: results of an expert panel. Crit Rev Oncol Hematol (2007) 0.92
A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples. Anticancer Res (2012) 0.91
Extensive molecular analysis of patients bearing CFTR-related disorders. J Mol Diagn (2011) 0.91
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study. Lung Cancer (2013) 0.90
Positron Emission Tomography (PET) radiotracers in oncology--utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC). J Exp Clin Cancer Res (2008) 0.90
Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literature. Eur J Gastroenterol Hepatol (2013) 0.90
Biological and clinical features in predicting efficacy of epidermal growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis. Anticancer Res (2009) 0.90
Mixed acid-base disorders, hydroelectrolyte imbalance and lactate production in hypercapnic respiratory failure: the role of noninvasive ventilation. PLoS One (2012) 0.89
Analysis of sputum markers in the evaluation of lung inflammation and functional impairment in symptomatic smokers and COPD patients. Dis Markers (2011) 0.88
Targeted therapy in combination with gemcitabine in non-small cell lung cancer. Semin Oncol (2003) 0.88
Three novel CFTR polymorphic repeats improve segregation analysis for cystic fibrosis. Clin Chem (2009) 0.87
High prevalence of bilateral transverse sinus stenosis-associated IIHWOP in unresponsive chronic headache sufferers: pathogenetic implications in primary headache progression. Cephalalgia (2011) 0.87
Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study. Med Oncol (2013) 0.86
Surgical treatment of stage III thymic tumors: a multi-institutional review from four Italian centers. Eur J Cardiothorac Surg (2010) 0.86
Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis (2007) 0.86
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD. Respir Med (2013) 0.85
Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy. FEBS J (2009) 0.85
Liver protein profiling in chronic hepatitis C: identification of potential predictive markers for interferon therapy outcome. J Proteome Res (2011) 0.85
Incidental endometrial adenocarcinoma in early pregnancy: a case report and review of the literature. Int J Gynecol Cancer (2009) 0.85
Safety and effectiveness of a new fibrin pleural air leak sealant: a multicenter, controlled, prospective, parallel-group, randomized clinical trial. Ann Thorac Surg (2011) 0.85
Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis. Am J Clin Pathol (2011) 0.84
Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients. J Thorac Oncol (2014) 0.84
Neurotrophin system expression in human pulmonary carcinoid tumors. Growth Factors (2005) 0.84
Prognostic value of p16-INK4A protein in women with negative or CIN1 histology result: a follow-up study. Int J Cancer (2013) 0.83
The red blood cell as a biosensor for monitoring oxidative imbalance in chronic obstructive pulmonary disease: an ex vivo and in vitro study. Antioxid Redox Signal (2006) 0.83
ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization. Int J Surg Pathol (2013) 0.82
Effect of insulin on airway responsiveness in patients with type 2 diabetes mellitus: a cohort study. J Asthma (2009) 0.82
Electrocardiographic abnormalities in thalassemia patients with heart failure. Cardiovasc Hematol Disord Drug Targets (2009) 0.82
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study. Lung Cancer (2011) 0.82
Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology (AIOT) clinical practice guidelines. Lung Cancer (2011) 0.82
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment. BJU Int (2012) 0.81
Prolonged remission of disseminated atypical adenomatous hyperplasia under gefitinib. J Thorac Oncol (2009) 0.81
Histomorphometric characteristics of first trimester chorionic villi in pregnancies with low serum pregnancy-associated plasma protein-A levels: relationship with placental three-dimensional power doppler ultrasonographic vascularization. J Matern Fetal Neonatal Med (2010) 0.81
Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients. J Transl Med (2014) 0.81
Prognostic value of vascular endothelial growth factor tumor tissue content of colorectal cancer. Oncology (2005) 0.81
Prolonged gemcitabine infusion in advanced non-small cell lung carcinoma: a randomized phase II study of two different schedules in combination with cisplatin. Cancer (2003) 0.81
Human neutrophil peptides stimulate tumor necrosis factor-alpha release by alveolar macrophages from patients with sarcoidosis. Chest (2009) 0.81
Long-term disease-free survival of a patient with synchronous bilateral lung adenocarcinoma displaying different EGFR and C-MYC molecular characteristics. Chest (2011) 0.80